Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel
Crossref DOI link: https://doi.org/10.1007/s12032-021-01509-7
Published Online: 2021-04-27
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mehdizadeh, Kayhan
Ataei, Farangis http://orcid.org/0000-0001-8682-9503
Hosseinkhani, Saman
Text and Data Mining valid from 2021-04-27
Version of Record valid from 2021-04-27
Article History
Received: 3 March 2021
Accepted: 5 April 2021
First Online: 27 April 2021
Declarations
:
: There is no conflict of interest to disclose.
: All authors agree to submit this article for publication.